Impact of social determinants of health on genomic testing among patients with advanced/metastatic non-small cell lung cancer.
193 Background: Guideline-concordant care for non-small cell lung cancer (NSCLC) is highly dependent on genomic testing to inform targeted therapy selection. Studies have reported persistent gaps in testing associated with racial and ethnic factors. Understanding the impact of social determinants of health (SDO...